Kevin P. Hourican

(Chair of the Board)

Executive Experience:

• CEO of the Company (2020-present), and Chair of the Board (2024-present). He has served as a member of Sysco’s Board since 2020. Leading the Company’s large-scale, customer-focused and growth-related transformation, aimed at further improving the way Sysco supports its customers and accelerating profitable sales growth. Since Mr. Hourican joined Sysco, the Company’s focus on elevating customer experience, expanding our specialty distribution reach, and penetrating new international markets has resulted in consistent market share gains and record-breaking financial performance.
• Executive Vice President of CVS Health Corporation, a premier health innovation company, and President of CVS Pharmacy, overseeing CVS Health’s $85 billion retail business, including 9,900 retail stores and over 200,000 employees, as well as merchandising, marketing, supply chain, real estate, front store operations, pharmacy growth, pharmacy clinical care and pharmacy operations.
• Held executive leadership roles at Macy’s prior to joining CVS Health.

Other Public Company Board Experience and Business Organizations:

• Director of Tapestry, Inc. (NYSE: TPR) (2024-present).
• Member of the Wall Street Journal CEO Council (2020-present) and the Business Roundtable (2020-present).

Key Director Qualifications and Board Contributions:

• Mr. Hourican’s various operations and management positions within CVS Health and Macy’s and his experience at Sysco, demonstrates his extensive experience and knowledge in the areas of executive leadership and management, corporate strategy development, distribution and supply chain management, merchandising and marketing.
• The Governance Committee and the Board believe that it is appropriate and beneficial to Sysco to have its CEO serve as management’s voice on the Board.